OIM

Oracle Investment Management Portfolio holdings

AUM $116M
1-Year Est. Return 84.31%
This Quarter Est. Return
1 Year Est. Return
+84.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$154M
AUM Growth
+$4.66M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
20
New
Increased
Reduced
Closed

Top Buys

1
+$12.2M
2
+$4.5M
3
+$1.55M
4
RXRX icon
Recursion Pharmaceuticals
RXRX
+$635K
5
PLTR icon
Palantir
PLTR
+$84.4K

Top Sells

1
+$4.74M
2
+$4.47M
3
+$4.03M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
+$1.18M
5
PACB icon
Pacific Biosciences
PACB
+$512K

Sector Composition

1 Healthcare 97.33%
2 Technology 1.62%
3 Consumer Discretionary 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WGS icon
1
GeneDx Holdings
WGS
$3.47B
$85.9M 43.34%
969,954
-53,514
SWTX
2
DELISTED
SpringWorks Therapeutics
SWTX
$23.4M 11.83%
531,351
+276,578
BHVN icon
3
Biohaven
BHVN
$1.69B
$16M 8.08%
665,945
-185,825
ARDX icon
4
Ardelyx
ARDX
$1.21B
$11.8M 5.96%
2,404,438
+315,007
TDOC icon
5
Teladoc Health
TDOC
$1.51B
$4.5M 2.27%
+565,900
QDEL icon
6
QuidelOrtho
QDEL
$1.91B
$4.14M 2.09%
118,291
FORA icon
7
Forian
FORA
$66M
$2.73M 1.38%
1,366,107
PLTR icon
8
Palantir
PLTR
$423B
$2.49M 1.26%
29,500
+1,000
CAVA icon
9
CAVA Group
CAVA
$7.29B
$1.61M 0.81%
18,600
RXRX icon
10
Recursion Pharmaceuticals
RXRX
$2.56B
$635K 0.32%
+120,000
BIIB icon
11
Biogen
BIIB
$21B
$330K 0.17%
2,412
XLV icon
12
Health Care Select Sector SPDR Fund
XLV
$35.3B
– –
0
BCRX icon
13
BioCryst Pharmaceuticals
BCRX
$1.4B
– –
-535,558
EYPT icon
14
EyePoint Pharmaceuticals
EYPT
$939M
– –
-32,500
NVAX icon
15
Novavax
NVAX
$1.32B
– –
0
PACB icon
16
Pacific Biosciences
PACB
$493M
– –
-279,638
PHAT icon
17
Phathom Pharmaceuticals
PHAT
$919M
– –
-145,064
PTON icon
18
Peloton Interactive
PTON
$3.06B
– –
0
VKTX icon
19
Viking Therapeutics
VKTX
$3.77B
– –
0
XNTK icon
20
SPDR NYSE Technology ETF
XNTK
$1.45B
– –
0